Krebs Biochemicals & Industries Stock Screener | Share Price & Fundamental Analysis
KREBSBIO
Pharmaceuticals
Screen Krebs Biochemicals & Industries share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹66.91
▲
0.08 (0.12%)
Share Price BSE
₹65.87
▼
-2.24 (-3.29%)
Market Cap
₹153.68 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
-0.96
EPS (TTM)
₹-12.49
Dividend Yield
-
Debt to Equity
-
52W High
₹80.70
52W Low
₹64.54
Operating Margin
-59.00%
Profit Margin
-96.43%
Revenue (TTM)
₹28.00
EBITDA
₹-15.00
Net Income
₹-27.00
Total Assets
₹169.00
Total Equity
₹-146.00
Krebs Biochemicals & Industries Share Price History - Stock Screener Chart
Screen KREBSBIO historical share price movements with interactive charts. Analyze price trends and patterns.
Krebs Biochemicals & Industries Company Profile - Fundamental Screener
Screen Krebs Biochemicals & Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KREBSBIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE268B01013
Krebs Biochemicals & Industries Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen KREBSBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 169 | 178 | 175 | 190 | 159 | 134 | 142 | 126 | 122 | 116 |
| Current Assets | 10 | 17 | 16 | 36 | 21 | 19 | 31 | 17 | 13 | 9 |
| Fixed Assets | 146 | 150 | 147 | 139 | 118 | 105 | 101 | 101 | 102 | 93 |
| Liabilities | ||||||||||
| Total Liabilities | 169 | 178 | 175 | 190 | 159 | 134 | 142 | 126 | 122 | 116 |
| Current Liabilities | 212 | 236 | 225 | 187 | 154 | 116 | 102 | 101 | 89 | 74 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -146 | -119 | -100 | -75 | -43 | -25 | -14 | -18 | 2 | 13 |
| Share Capital | 22 | 22 | 22 | 22 | 20 | 18 | 17 | 14 | 14 | 13 |
| Reserves & Surplus | -168 | -141 | -121 | -97 | -67 | -43 | -31 | -32 | -12 | -4 |
Krebs Biochemicals & Industries Income Statement Screener - Profit & Revenue Analysis
Intrinsic ValueScreen KREBSBIO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28 | 44 | 51 | 53 | 61 | 54 | 34 | 48 | 34 | 3 | 2 | 0 |
| Expenses | 42 | 58 | 59 | 68 | 94 | 71 | 52 | 58 | 41 | 11 | 14 | 5 |
| EBITDA | -15 | -14 | -8 | -15 | -33 | -17 | -18 | -10 | -7 | -8 | -11 | -5 |
| Operating Profit % | -59.00% | -35.00% | -17.00% | -30.00% | -57.00% | -33.00% | -56.00% | -21.00% | -22.00% | -246.00% | -962.00% | 0.00% |
| Depreciation | 7 | 7 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 4 | 5 | 2 |
| Interest | 7 | 6 | 5 | 3 | 5 | 6 | 6 | 6 | 5 | 4 | 1 | 4 |
| Profit Before Tax | -27 | -27 | -20 | -25 | -45 | -28 | -29 | -20 | -18 | -16 | -16 | -8 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -27 | -27 | -20 | -25 | -45 | -28 | -29 | -20 | -18 | -16 | -16 | -8 |
| EPS | -12.70 | -12.49 | -9.15 | -11.30 | -20.81 | -14.37 | -17.90 | -12.83 | -12.97 | -11.68 | -12.49 | -8.24 |
Krebs Biochemicals & Industries Cash Flow Screener - Liquidity Fundamentals
Screen KREBSBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | 2 | -25 | -17 | -15 | -36 | 4 | -6 | -11 | -15 |
| Investing Activities | -5 | -8 | -13 | -23 | -23 | -10 | -4 | -3 | -5 | -4 |
| Financing Activities | 13 | 6 | 37 | 40 | 38 | 29 | 17 | 9 | 16 | 13 |
| Net Cash Flow | 0 | 0 | 0 | -1 | 1 | -17 | 17 | 0 | 0 | -6 |
Screen KREBSBIO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| FII Holding | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.01% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.70% | 19.73% | 20.42% | 20.02% | 19.80% | 19.97% | 20.11% | 18.57% |
| Other Holding | 7.06% | 7.03% | 6.34% | 6.74% | 6.96% | 6.79% | 6.65% | 8.68% |
| Shareholder Count | 8,912 | 9,118 | 8,798 | 9,091 | 9,425 | 8,848 | 8,909 | 9,294 |
Krebs Biochemicals & Industries Dividend Screener - Share Yield Analysis
Screen KREBSBIO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Krebs Biochemicals & Industries Index Membership - Market Screener Classification
Screen KREBSBIO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Krebs Biochemicals & Industries Market Events Screener - Corporate Actions
Screen KREBSBIO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.51% | ||
| Annual General Meeting | NA | 0.87% | ||
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | -2.74% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -3.19% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 6.47% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 7.47% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 19.99% |
| 2019-01-31 | 2019-02-01 | Rights | 21:100 | -11.42% |
Krebs Biochemicals & Industries Competitors Screener - Peer Comparison
Screen KREBSBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Krebs Biochemicals & Industries Company Announcements - News Screener
Screen KREBSBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-09 | Closure of Trading Window | View |
| 2025-12-03 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares Nov 2025 | View |
| 2025-11-18 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares Oct 2025 | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Result Sept 2025 | View |
| 2025-11-04 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-16 | Board Meeting Intimation for Board Meeting Intimation For The Quarter Ended 30.09.2025. | View |
| 2025-10-08 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-23 | Closure of Trading Window | View |
| 2025-09-11 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-28 | Notice Of 33Rd Annual General Meeting Of The Company | View |
| 2025-08-28 | Reg. 34 (1) Annual Report. | View |
| 2025-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-07 | Board Comments On Fine Levied By Exchanges | View |
| 2025-08-07 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-07 | Result | View |